ImetelChat

Well volleyed, Ryan

Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that it has granted equity awards covering an aggregate of 1,551,000 shares of its common stock, consisting of stock options to purchase an aggregate of 1,034,000 shares of common stock and restricted stoc...

Since I don't have the proper materials yet from Geron to vote my proxy, I emailed this to Investor Relations to give them my sentiment. Hopefully it will convey what sought to do with actual voting. How about others doing the same? Tue, Apr 15, 10:30 AM (20 hours ago) to investor Relations I wish t...

I have no control number. I got the proxy notice but no control number to allow me to vote.

I too would like to vote no on all proposals as a protest to share price and lack of transparency. I have not gotten proxy. Is there a way of getting my vote in now?

Suggesting how to vote? Isn't that what opinions are? If we don't have a large number of people voting in one direction, what is the point of your recommendation to wait? To have an impact, we need to have as large number as we can find.

I like voting as a block via same date. But we best vote the same. Can we agree on our stances?

My limited understanding is that misleading remarks were made, by Chip especially, that were overly optimistic as far as projected income. I have wondered if that was a major factor in Chip's being terminated by Geron. I believe some believe this is the second time he has exposed the company to this...

I wonder the attempts at suing Geron have hurt the pps. Bad publicity. My recall is that Geron carries insurance to cover these quicky lawsuits. Is that right?

Happy note. Glad to see the announcements today for earnings and infomercials.

Dear Dr Jay, Thank you for writing to the European Medicines Agency (EMA) on 3 March 2025 to ask about the authorisation of Rytelo, a medicine containing the active substance imetelstat, for use within the European Union (EU). After a positive opinion from EMA’s human medicines committee (the CHMP),...

Attn: Ms. Dawn C Bir, Interim President & CEO Attn: Ms. Elizabeth G.O'Farrell, Chair, Board of Directors Dear Ms.Bir and Ms. O'Farrell, I have been an investor in Geron for about twenty-five years and now hold over 350,000 shares. I have become increasingly concerned about the low share price, given...

Thank you Stanley! Great letter. I will write one myself today.
DR. J

FOSTER CITY, Calif.--(BUSINESS WIRE)-- Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that John “Chip” A. Scarlett, M.D., President, Chief Executive Officer and Chairman, will depart the co...

The approval was done last Friday. And no public announcement. What the heck? Hopefully the geron team is busy arranging European partner.

https://www.ema.europa.eu/en/medicines/ ... PAR/rytelo

And no announcement from Geron. This is scary!

I agree! The Geron board needs to announce action to right the stock price. Perhaps we can send a group letter or a mass of individual emails to Geron telling them our concerns?

At first I thought it a quick nothing burger, but on reflection I wondered what business suddenly comes up after they planned these presentations? Buyout or merger are about all I got...maybe EU approval issures?
Aside-all of a sudden huge buy volumes.

Hi Dr. J Thank you for reaching out. Our sincerest apologies, but we are no longer able to attend the Barclay's and Leerink conferences due to last minute scheduling conflicts that prevent us from traveling. The management team has a full schedule over the coming weeks as they are focused on managin...

I just sent email to Geron asking why they cancelled the two conferences. Good luck

Please elaborate Bio-
Yahoo boarder speculates it has to do with a buyout in the works. that could make sense.